Table 1.
Population characteristics.
| Clinical parameters | Value | (N) % |
|---|---|---|
| Age (years) | 64.8 ± 9.3 | |
| Males | (63) 86 | |
| Systolic blood pressure (mm Hg) | 120.5 ± 10.2 | |
| Heart rate (bpm) | 70.6 ± 13.2 | |
| Arterial hypertension | (50) 68 | |
| Diabetes % | (28) 38 | |
| COPD | (24) 32 | |
| Chronic kidney disease (%) | (13) 18 | |
| Atrial fibrillation (%) | (27) 37 | |
| LVEF (%) | 33.1 ± 6.3 | |
| LV end-diastolic diameter (mm) | 62.8 ± 7.7 | |
| LA diameter (mm) | 45.8 ± 6.2 | |
| Creatinine (mg/dl) | 1.15 ± 0.42 | |
| Serum potassium (mEq/L) | 4.48 ± 0.48 | |
| NTproBNP | 628.4 ± 3089.2 | |
| Drug therapy | (N) % | |
| Beta-blockers | (70) 96 | |
| Furosemide | (59) 81 | |
| Spironolactone | (46) 63 | |
| Ivabradine | (25) 34 | |
| Digoxin | (2) 3 | |
| Amiodarone | (30) 41 | |
| Aspirin | (41) 56 | |
| OAC | (32) 44 | |